Cerebrotendinous Xanthomatosis
What is Cerebrotendinous Xanthomatosis?
Cerebrotendinous xanthomatosis is a rare genetic disorder that affects how your body processes fats. Your body struggles to break down certain types of cholesterol and fats properly. This causes cholesterol and other fatty substances to build up in your tendons, brain, and other tissues over time.
The condition is inherited, meaning it passes from parents to children through genes. Both parents must carry the gene mutation for a child to develop the disorder. People with this condition have problems making bile acids, which are substances your liver produces to help digest fats.
Early detection and treatment can help prevent or slow serious complications. The buildup of cholesterol in tissues can affect your nervous system, eyes, heart, and other organs. With proper monitoring and medication, many people with this condition can manage symptoms and maintain quality of life.
Symptoms
- Chronic diarrhea starting in infancy or childhood
- Clouding of the eye lens, called cataracts, often appearing in childhood
- Fatty lumps or thickening in tendons, especially Achilles tendons
- Progressive difficulty with coordination and balance
- Cognitive decline or learning difficulties
- Seizures or episodes of confusion
- Muscle stiffness or weakness
- Behavioral changes or psychiatric symptoms
- Vision problems beyond cataracts
- Bone fractures or osteoporosis
Symptoms often start in childhood but may not be recognized as a pattern until later. Some people have mild symptoms early on, while others experience more severe problems. The condition is progressive, meaning symptoms typically worsen without treatment.
Concerned about Cerebrotendinous Xanthomatosis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Cerebrotendinous xanthomatosis is caused by mutations in the CYP27A1 gene. This gene provides instructions for making an enzyme that helps your body produce bile acids. When the enzyme does not work properly, your body cannot break down cholesterol normally. The result is a buildup of cholesterol and cholestanol, a cholesterol-like substance, in your tissues.
The condition follows an autosomal recessive pattern of inheritance. This means you must inherit one mutated gene from each parent to develop the disorder. Parents who each carry one mutated gene are called carriers. They typically do not have symptoms themselves. If both parents are carriers, each child has a 25 percent chance of having the condition.
How it's diagnosed
Diagnosis involves genetic testing to look for mutations in the CYP27A1 gene. Doctors may also measure cholestanol levels in your blood, as these are typically elevated in people with this condition. Blood tests can check total cholesterol levels, though they may appear normal or even low in some cases. Regular monitoring of cholesterol and other biomarkers helps track disease progression and treatment response.
Rite Aid offers blood testing that includes total cholesterol measurement as part of routine health monitoring. While specialized testing for cholestanol and genetic confirmation requires additional laboratory work, monitoring your cholesterol profile provides valuable baseline information. Your doctor may order brain imaging, eye exams, and other specialized tests to assess tissue damage and plan treatment.
Treatment options
- Chenodeoxycholic acid, a bile acid replacement medication, is the primary treatment
- Daily medication helps reduce cholestanol production and buildup in tissues
- Regular monitoring of cholesterol levels and liver function
- Dietary changes to reduce cholesterol and fat intake may help
- Physical therapy to maintain mobility and manage muscle stiffness
- Statins or other cholesterol-lowering medications in some cases
- Treatment for seizures if they occur
- Cataract surgery when vision is affected
- Regular neurological assessments to track disease progression
- Genetic counseling for family planning
Concerned about Cerebrotendinous Xanthomatosis? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
The earliest signs often include chronic diarrhea in infancy and childhood cataracts appearing before age 10. Some children may also have delayed motor development or learning difficulties. Fatty deposits in tendons typically appear later, often in teenage years or early adulthood.
Unlike typical high cholesterol, this condition involves a genetic defect in bile acid production. Blood cholesterol levels may actually be normal or low. The problem is that cholestanol, a different cholesterol-like substance, builds up in tissues instead of being processed correctly.
There is no cure, but treatment with chenodeoxycholic acid can prevent or slow progression. Starting treatment early, ideally before significant organ damage occurs, leads to better outcomes. Many people on treatment can manage symptoms and maintain good quality of life.
This is a rare genetic disorder affecting roughly 1 in 50,000 to 1 in 70,000 people worldwide. Some populations have higher rates due to genetic founder effects. Many cases go undiagnosed or are diagnosed late because symptoms can be mistaken for other conditions.
Total cholesterol testing provides baseline monitoring, though levels may be misleadingly normal. Specialized testing measures cholestanol levels, which are typically elevated 10 to 50 times above normal. Bile acid levels and liver function tests also help track treatment effectiveness.
Lifestyle changes alone cannot treat this genetic condition. However, a diet lower in fats and cholesterol may support medical treatment. Physical therapy helps maintain mobility and manage neurological symptoms. Medication remains essential for preventing disease progression.
Yes, this condition is inherited in an autosomal recessive pattern. Both parents must carry the mutated gene for a child to develop the disorder. Each child of two carriers has a 25 percent chance of having the condition and a 50 percent chance of being a carrier.
Without treatment, the condition causes progressive neurological damage, including dementia, movement disorders, and seizures. Cardiovascular problems may develop due to cholesterol deposits in arteries. Early cataracts, osteoporosis, and tendon xanthomas worsen over time.
Women with this condition can have healthy pregnancies with proper medical management. Continuing chenodeoxycholic acid treatment during pregnancy is usually recommended, as stopping it may worsen symptoms. Genetic counseling helps families understand inheritance risks for their children.
Regular monitoring every 3 to 6 months is typical, especially when starting or adjusting treatment. Blood tests check cholestanol levels and liver function. Your doctor may also order periodic neurological assessments and imaging to track disease progression and treatment response.